Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,067Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 11Indoco Remedies Limited

02 5MSN Laboratories

03 39Takeda Pharmaceutical

04 6Takeda Pharmaceuticals Australia Pty. Ltd.

05 5Torrent Pharmaceuticals Limited

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ALOGLIPTIN BENZOATE

Brand Name : ALOGLIPTIN

Dosage Form : TABLET;ORAL

Dosage Strength : 6.25MG

Packaging :

Approval Date :

Application Number : 210002

Regulatory Info :

Registration Country : USA

blank

02

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ALOGLIPTIN AND METFORMIN HYDROCHLORIDE

Brand Name : ALOGLIPTIN AND METFORMIN HYDROCHLORIDE

Dosage Form : TABLET; ORAL

Dosage Strength : 12.5MG/500MG

Packaging :

Approval Date :

Application Number : 210212

Regulatory Info :

Registration Country : USA

blank

03

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ALOGLIPTIN AND METFORMIN HYDROCHLORIDE

Brand Name : ALOGLIPTIN AND METFORMIN HYDROCHLORIDE

Dosage Form : TABLET; ORAL

Dosage Strength : 12.5MG/1000MG

Packaging :

Approval Date :

Application Number : 210212

Regulatory Info :

Registration Country : USA

blank

04

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ALOGLIPTIN BENZOATE

Brand Name : ALOGLIPTIN

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 6.25MG BASE

Packaging :

Approval Date :

Application Number : 210213

Regulatory Info :

Registration Country : USA

blank

05

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ALOGLIPTIN BENZOATE

Brand Name : ALOGLIPTIN

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 12.5MG BASE

Packaging :

Approval Date :

Application Number : 210213

Regulatory Info :

Registration Country : USA

blank

06

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ALOGLIPTIN BENZOATE

Brand Name : ALOGLIPTIN

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 25MG BASE

Packaging :

Approval Date :

Application Number : 210213

Regulatory Info :

Registration Country : USA

blank

07

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ALOGLIPTIN BENZOATE

Brand Name : NESINA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 6.25MG BASE

Packaging :

Approval Date : 2013-01-25

Application Number : 22271

Regulatory Info : RX

Registration Country : USA

blank

08

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ALOGLIPTIN BENZOATE

Brand Name : NESINA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 12.5MG BASE

Packaging :

Approval Date : 2013-01-25

Application Number : 22271

Regulatory Info : RX

Registration Country : USA

blank

09

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ALOGLIPTIN BENZOATE

Brand Name : NESINA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 25MG BASE

Packaging :

Approval Date : 2013-01-25

Application Number : 22271

Regulatory Info : RX

Registration Country : USA

blank

10

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

Brand Name : OSENI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 25MG BASE;EQ 15MG BASE

Packaging :

Approval Date : 2013-01-25

Application Number : 22426

Regulatory Info : RX

Registration Country : USA

blank

11

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

Brand Name : OSENI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 25MG BASE;EQ 30MG BASE

Packaging :

Approval Date : 2013-01-25

Application Number : 22426

Regulatory Info : RX

Registration Country : USA

blank

12

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

Brand Name : OSENI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 25MG BASE;EQ 45MG BASE

Packaging :

Approval Date : 2013-01-25

Application Number : 22426

Regulatory Info : RX

Registration Country : USA

blank

13

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

Brand Name : OSENI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 12.5MG BASE;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2013-01-25

Application Number : 22426

Regulatory Info : DISCN

Registration Country : USA

blank

14

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

Brand Name : OSENI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 12.5MG BASE;EQ 30MG BASE

Packaging :

Approval Date : 2013-01-25

Application Number : 22426

Regulatory Info : RX

Registration Country : USA

blank

15

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

Brand Name : OSENI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 12.5MG BASE;EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2013-01-25

Application Number : 22426

Regulatory Info : DISCN

Registration Country : USA

blank

16

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE

Brand Name : KAZANO

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 12.5MG BASE;500MG

Packaging :

Approval Date : 2013-01-25

Application Number : 203414

Regulatory Info : RX

Registration Country : USA

blank

17

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE

Brand Name : KAZANO

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 12.5MG BASE;1GM

Packaging :

Approval Date : 2013-01-25

Application Number : 203414

Regulatory Info : RX

Registration Country : USA

blank

18

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

alogliptinbensoat

Brand Name : Vipidia

Dosage Form : FILMDRAGERAD TABLETT

Dosage Strength : 6,25 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

19

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ALOGLIPTIN; METFORMIN HYDROCHLORIDE

Brand Name : ALOGLIPTIN; METFORMIN HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 12.5MG BASE;500MG

Packaging :

Approval Date :

Application Number : 210160

Regulatory Info :

Registration Country : USA

blank

20

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ALOGLIPTIN; METFORMIN HYDROCHLORIDE

Brand Name : ALOGLIPTIN; METFORMIN HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 12.5MG BASE;1GM

Packaging :

Approval Date :

Application Number : 210160

Regulatory Info :

Registration Country : USA

blank